Literature DB >> 887800

Dual effects of bradykinin on prostaglandin metabolism: relationship to the dissimilar vascular actions of kinins.

P Y Wong, D A Terragno, N A Terragno, J C McGiff.   

Abstract

Generation of a prostaglandin of the F series by bovine mesenteric veins in response to bradykinin may depend on increased synthesis of PGE and conversion of the latter to PGF after activation of PGE 9-ketoreductase by the kinin. The prostaglandin then mediates the constrictor action of bradykinin on the bovine mesenteric vein. A high speed supernatant (HSS) fraction of bovine mesenteric blood vessels contains the highest activity of PGE 9-ketoreductase. Incubation of PGE2 with HSS at 37 degrees C in the presence of a NADPH generating system resulted in time-dependent conversion of PGE2 to PGF2alpha. Bradykin (0.01mM) more than doubled conversion of PGE2 to PGF2alpha by the PGE 9-ketoreductase obtained from mesenteric veins whereas the kinin had little effect on enzymic activity of the HSS fraction of mesenteric arteries. However, after inhibition of kininase catabolism, bradykinin increased PGE 9-ketoreductase activity of arteries and veins to the same degree. Prostaglandin release from veins by bradykinin appears essential to contraction of mesenteric venous strips evoked by the polypeptide as indomethacin treatment abolished this effect. PGE 9-ketoreductase may be an important prostaglandin regulatory mechanism of the vascular wall whereby the functional consequences of changes in rates of prostaglandin synthesis are governed by determining the ratio of PGE to PGF within vascular tissue. Constriction of bovine mesenteric veins evoked by bradykinin may, therefore, depend on increased prostaglandin synthesis and conversion of newly formed PGE to PGF, both steps being affected by the kinin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 887800     DOI: 10.1016/0090-6980(77)90138-1

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  10 in total

1.  Mediation of bradykinin-induced contraction in canine veins via thromboxane/prostaglandin endoperoxide receptor activation.

Authors:  M O Aksoy; C Harakal; J B Smith; G J Stewart; C R Zerweck
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

2.  Prostaglandins and skeletal muscle glucose uptake.

Authors:  W H Hartl
Journal:  Biochem J       Date:  1987-12-01       Impact factor: 3.857

3.  The bradykinin-induced coronary vasodilation. Evidence for an additional prostacyclin-independent mechanism.

Authors:  K Schrör; U Metz; R Krebs
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-07       Impact factor: 3.000

4.  The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats.

Authors:  H M Siragy; R M Carey
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

Review 5.  Renal prostaglandins.

Authors:  J C FrOlich; G Fejes-Toth
Journal:  Klin Wochenschr       Date:  1982-09-15

Review 6.  The kallikrein-kinin system in circulatory and metabolic homeostasis.

Authors:  R McConn; G L Haberland; J C Frölich
Journal:  World J Surg       Date:  1981-07       Impact factor: 3.352

Review 7.  [Prostaglandins in cardiovascular and renal function. Biochemical, physiological and clinical findings (author's transl)].

Authors:  P C Weber; W Siess; B Scherer
Journal:  Klin Wochenschr       Date:  1979-05-03

8.  [Reduced urinary prostaglandin E2-excretion and diminished responsiveness of plasma renin activity in patients with essential hypertension (author's transl)].

Authors:  B Scherer; E Held; H H Lange; P C Weber
Journal:  Klin Wochenschr       Date:  1979-06-01

9.  Reduction of the bradykinin-induced activation of feline group III and IV muscle receptors by acetylsalicylic acid.

Authors:  S Mense
Journal:  J Physiol       Date:  1982-05       Impact factor: 5.182

10.  Identification of 6-oxo-prostaglandin E1 as a naturally occurring prostanoid generated by rat lung.

Authors:  C N Berry; R J Griffiths; J R Hoult; P K Moore; G W Taylor
Journal:  Br J Pharmacol       Date:  1986-02       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.